Deiodination is the foremost pathway of thyroid hormone metabolism not only in quantitative terms but also because thyroxine (T 4 ) is activated by outer ring deiodination (ORD) to 3,3',5-triiodothyronine (T 3 ), whereas both T 4 and T 3 are inactivated by inner ring deiodination (IRD) to 3,3',5-triiodothyronine and 3,3'-diiodothyronine, respectively. These reactions are catalyzed by three iodothyronine deiodinases, D1-3. Although they are homologous selenoproteins, they differ in important respects such as catalysis of ORD and/or IRD, deiodination of sulfated iodothyronines, inhibition by the thyrostatic drug propylthiouracil, and regulation during fetal and neonatal development, by thyroid state, and during illness. In this review we will briefly discuss recent developments in these different areas. These have resulted in the emerging view that the biological activity of thyroid hormone is regulated locally by tissue-specific regulation of the different deiodinases.
T
HYROID HORMONE is essential for growth, development, and regulation of energy metabolism (1) (2) (3) . Amphibian metamorphosis is an important example of thyroid hormone actions on development (4) . Equally well known is the critical role of thyroid hormone in development and function of the human central nervous system (5, 6) . Thyroid hormone is produced by the thyroid in the form of the biologically inactive precursor thyroxine (T 4 ). The prinicipal bioactive form of the hormone is triiodothyronine (T 3 ). In humans, only approximately 20% of T 3 is secreted by the thyroid; most circulating T 3 is derived from outer ring deiodination (ORD) of T 4 in peripheral tissues. Both T 4 and T 3 undergo inner ring deiodination (IRD) to metabolites which do not interact with T 3 receptors, reverse triiodothyronine (rT 3 ) and 3,3Ј-diiodothyronine (3,3Ј-T 2 ), respectively. Thus, ORD is regarded as an activating pathway and IRD as an inactivating pathway. ORD is also the main pathway for the metabolism of rT 3 , representing another route for the generation of 3,3Ј-T 2 . Three iodothyronine deiodinases are involved in the deiodination of iodothyronines, namely, D1-D3 (7) (8) (9) .
In humans and rodents, D1 is located primarily in liver, kidney, and thyroid. Lower D1 activities are expressed in other tissues, including rat anterior pituitary. Although D1 has both ORD and IRD activities, it appears particularly important for the generation of plasma T 3 and clearance of plasma rT 3 . ORD of rT 3 is the most efficient reaction catalyzed by D1, while IRD of both T 4 and T 3 are strongly accelerated by sulfation of these iodothyronines. Michaelis Menten constant (K m ) values for substrates of D1 are in the micromolar range. The enzyme is potently inhibited by the thyrostatic drug 6-propyl-2-thiouracil (PTU). D1 activity is positively regulated by T 3 , reflecting regulation of D1 expression by T 3 at the pretranslational level.
In humans, D2 activity is found in brain, anterior pituitary, placenta, thyroid and skeletal muscle, and D2 mRNA has also been detected in the human heart. In rodents D2 is also expressed in brown adipose tissue. D2 has only ORD activity, preferring T 4 over rT 3 as the substrate, with apparent K m values in the nanomolar range. In general, D2 activity is increased in hypothyroidism and decreased in hyperthyroidism. Both pre-and posttranslational mechanisms are involved in the regulation of D2 expression by thyroid state, with distinct roles for T 3 , and for T 4 and rT 3 , respectively. Although perhaps D2 in skeletal muscle may contribute to circulating T 3 , the enzyme is particularly important for local T 3 production in brain and anterior pituitary.
In human and rodents, D3 is located in brain, placenta, pregnant uterus, and fetal tissues. D3 has only IRD activity, and is thus important for the inactivation of thyroid hormone. It shows preference for T 3 over T 4 as the substrate, with apparent K m values in the nanomolar range. The high D3 activity in placenta, pregnant uterus and different fetal tissues seems to serve the purpose of protecting the fetus against undue exposure to active thyroid hormone that may be detrimental for the development of different tissues, in particular the brain. In brain, D3 activity is increased in hyperthyroidism and decreased in hypothyroidism but the mechanism of this regulation remains to be established.
In this short review we will focus on recent insights in deiodinase structure-function relationships and physiological roles of deiodinases. For a more in-depth discussion on the concepts underlying much of the work to be presented the reader is referred to earlier reviews (8) (9) (10) (11) .
Structure-Function Relationship of Iodothyronine Deiodinases

Catalytic center
Iodothyronine deiodinases are selenoproteins, containing a single selenocysteine residue (SeC) in the core catalytic center. This core catalytic center consists of approximately 15 amino acid residues surrounding the SeC and is highly conserved within and between the deiodinase subtypes. The SeC is encoded by a UGA stop codon which in the presence of a so-called SECIS (selenocysteine insertion sequence) element in the 3Ј untranslated region (UTR) is recoded from a stop to a SeC codon (12) . The SeC residue is essential for enzyme activity because replacement with Ala or Ser residues (essentially replacing the SeH group by H or OH) eliminates activity. As far as we know only replacement of SeC with Cys (substituting S for Se) in D1, D2, or D3 maintains enzymatic activity, although with strongly reduced substrate turnover numbers and significantly increased K m values for the iodothyronine substrates (13) (14) (15) . For some reason during evolution nature has decided that deiodinases should be selenoenzymes, despite the fact that the synthesis of a selenoprotein is expensive for the cell. From an energetic point of view the extraction of iodonium (I ϩ ) from an aromatic ring is a difficult step and most likely the more negatively charged selenol group (SeH ↔ Se Ϫ ) is better capable of accomplishing this than the sulfydryl group (SH). The selenol group might interact with side groups of other amino acid residues facilitating its deprotonation. For D1 the formation of an essential imidazolium-selenolate ion pair was postulated on the basis of experiments with histidine-directed reagents and side-directed mutagenesis studies (8, 16, 17) .
More detailed insights in deiodinase structure and catalytic mechanism must come from the three-dimensional structure when this is resolved by crystallographic studies. Unfortunately, these studies are greatly hampered by the difficulties encountered with overexpressing these membraneintegrated enzymes in a soluble and active form. An alternative strategy consists of attempting to model deiodinase structure on the basis of structural resemblance to other proteins for which experimental structure information exists. Hydrophobic cluster analysis revealed that the extramembrane portion of deiodinases belongs to the thioredoxin-fold superfamily and that a region within this fold shared strong similarities with the active site of iduronidase (18) . This lowresolution deiodinase structural model consists of a single transmembrane domain and a hinge or linker domain connected to a globular domain containing the active center. The model provided novel information about conserved amino acid positions in the active center surrounding the core catalytic center with the SeC residue. These amino acid residues are very well conserved between the deiodinase subtypes and it was shown that variations of specific amino acid residues are linked to functional differences among D1, D2, and D3 (see below). The model involved part of the protein (from amino acid residue 75 up to the C-terminus) and did not provide structural information with regard to the transmembrane domain and adjacent region known to be involved in iodothyronine substrate interaction.
Iodothyronine substrate interaction
Cloning of D1 from various species (rat, mouse, cat, dog, human) and careful analysis of kinetic properties with a range of substrates (T 4 , T 3 , rT 3 , rT 3 S, T 2 , T 2 S) has enabled the identification of a region that is involved in substrate interaction. Comparative structural-functional analysis of human and dog D1 enzymes showed that the region between amino acid residue 30 and 70 accounts for the difference in K m value for rT 3 ORD between dog and human D1 (19) . Dog D1 has an approximately 30-fold higher K m for rT 3 ORD than human D1. More detailed studies demonstrated that it is mainly the Phe65Leu substitution that explains the slow ORD of rT 3 by dog D1 versus human and rat D1 (19) . The same type of studies comparing cat and rat D1 enzyme also indicated that the region between residue 40 and 70 is involved in substrate interaction. By site-directed mutagenesis it was found that a combination of mutations was necessary to improve the deiodination of rT 3 by cat D1. For efficient rT 3 deiodination, a Phe at position 65 and the insertion of the Thr-Gly-MetThr-Arg sequence (residue [48] [49] [50] [51] [52] as well as the amino acids Gly and Glu at position 45-46 are essential (20) . An intriguing property of cat D1 is the facilitated deiodination of rT 3 S, and the combination of the described changes did not affect this property (V max /K m rT 3 ϭ 3 and V max /K m rT 3 S ϭ 81). The negatively charged sulfate group of rT 3 S might interact with the positively charged side group of a basic amino acid (Lys, Arg), thereby stabilizing interaction with D1. Our studies indicated that this basic amino acid is probably situated outside the region between residue 40 and 70, and remains to be identified. The fact that D1 catalyzes ORD (rT 3 , rT 3 S, T 4 ) and IRD (T 4 , T 4 S, T 3 , T 3 S) suggests different orientations of substrate binding within a single site, so that either the iodines of the inner ring or of the outer ring are in close proximity of the catalytic center. In other words, the D1 substrate binding site is very flexible and therefore it will be difficult to gain more insight in the structure-activity relationship by site-directed mutagenesis studies with the thus far cloned D1 enzymes, unless D1 variants from other species turn up which for instance lack IRD activity or do not show facilitated deiodination of sulfated iodothyronines. For similar reasons, that is no large variations in kinetic properties for different substrates among D2 and D3 enzymes in various species, no progress has been made in the identification of substrate interacting regions in D2 or D3.
PTU inhibition of D1
A largely unsolved question concerns the basis for the potent inhibition of mammalian D1, but not teleost fish D1, by PTU. The catalytic cycle of D1 appears to exist of two half reactions: (1) transfer of an I ϩ from the substrate to the selenolate (Se Ϫ ) anion of SeC and (2) reduction of the selenenyl iodide (SeI) generated by a thiol cofactor. PTU inhibition of D1 is uncompetitive with iodothyronine substrate, and there is strong evidence that PTU reacts with the SeI intermediate ( Fig. 1) (17,21) . The selenenyl sulfide thus formed is considered to be a dead-end product because it does not react with thiols under physiologic conditions. D1 from various teleost fish species as killifish (Fundulus heteroclitus) and tilapia (Oreochromis niloticus) have greatly reduced sensitivity toward inhibition by PTU (IC 50 Ͼ 1000 M for tilapia D1 versus 1 M for human D1). Also, sensitivity for the other D1 inhibitors goldthioglucose (GTG) and iodoacetate (IAc) is reduced (22, 23) . Kinetic data suggest that GTG and IAc react with the SeC residue in its reduced (SeH) form (25) (Fig. 1) . We have recently characterized a Xenopus laevis D1 enzyme (K m T 4 and rT 3 ϭ 0.2 M) which is not inhibited by PTU and also displays reduced sensitivity for GTG and IAc (unpublished data). The PTU insensivity of teleost fish and ampibian D1 proteins might be related to a different catalytic mechanism not involving the formation of a SeI intermediate. However, that would not explain the reduced sensitivity toward GTG and IAc. More likely, the reduced sensitivity for GTG, IAc, and PTU reflects a decreased reactivity of the selenol group of the SeC residue as such. The substrate turnover number of tilapia D1, and probably also the other PTUinsensitive D1 enzymes, is strongly reduced in comparison to rat and human D1 (22) . The selenol group may interact with side chains of other amino acid residues, stimulating deprotonation at physiologic pH. In this regard it is interesting to note that the pI value of PTU-sensitive D1 enzymes is 9-10, whereas it is 6-7 for PTU insensitive D1 enzymes. At various positions in PTU-sensitive D1 enzymes basic or neutral amino acid residues are present were PTU-insensitive D1 enzymes have acidic or neutral amino acid residues. Whether these differences are related to D1 substrate turnover numbers and inhibitor profiles remains to be investigated. Apart from a putative role for residues outside the core catalytic center there is experimental evidence that residues in the immediate vicinity of the SeC residue play a role in determining PTU sensitivity. Within the core catalytic center surrounding the SeC residue the PTU-sensitive D1 enzymes all share the sequence Gly-Ser-Cys-Thr-SeC-Pro-Ser-Phe, while the PTU-insensitive D1 enzymes share the sequence Gly-Ser-Cys-Thr-SeC-ProPro-Phe. So, the residue 2 positions downstream from SeC is Pro in PTU-insentive D1 enzymes and Ser in PTU-sensitive D1 enzymes. As expected, the Ser to Pro mutation in the PTUsensitive human D1 enzyme (Ser128Pro) did decrease PTU sensitivity, but the reverse mutation in the PTU insensitive tilapia D1 enzyme (Pro128Ser) did not restore PTU sensitivity (18, 22) . In conclusion, amino acid residues in the immediate vicinity of the SeC residue influence PTU sensitivity, but there is also an important modifying role for residues in other segments of the D1 enzyme that remain to be elucidated.
Invertebrate deiodinases
All vertebrates (mammals, birds, teleost fish) have been shown to express D1, D2, and D3 activity, although they may differ with respect to tissue distribution, ontogenic profiles and other aspects such as substrate preference and inhibitor profile. Thus far, it was thought that iodothyronine deiodinases are vertebrate innovations, but the discovery of iodothyronines, homologues of iodothyronine deiodinases, and thyroid hormone receptors (TR) in invertebrates has shed new light on the coevolution of proteins involved in thyroid hormone synthesis, iodothyronine deiodinases and TRs (24) (25) (26) (27) .
Ascidians or sea squirts (for instance Ciona and Halocynthia) belong to the phylum Urochordata. They are often referred to as protochordates because during the larval stage they possess chordate characteristics, most notably the tail contains a notochord and a dorsal hollow nerve cord. After a free-swimming stage, the simple tadpole-like larvae attach to a substrate and undergo metamorphosis that includes tail loss and rearrangement of the internal organs. Subsequently, in the adult form, the similarities to chordates are lost. Although no clear role for thyroid hormones in adult ascidians has been established, there are studies suggesting a role for T 4 in the metamorphosis from the larval to the adult stage (28) . Indeed, the first evidence of an organ related to the vertebrate thyroid gland is found in protochordates. The ascidian endostyle is a mucus-secreting pharyngeal organ that facilitates filter feeding. The endostyle has iodine-concentrating activity, and the biosynthesis of thyroid hormone by this organ is well documented (25, 26 ). An endostyle is also found in cephalochordates (Amphioxus) and in larval lamprey, where it transforms into a follicular thyroid gland during metamorphosis (25) .
We have recently characterized an iodothyronine deiodinase from Halocyntha roretzi (hrDx) as a high-K m enzyme with ORD activity toward T 4 and rT 3 . This enzyme shows a temperature optimum between 20°C and 30°C and has kinetic characteristics resembling vertebrate D1 and D2 (29) . The 3Ј-UTR of the hrDx mRNA contains a SECIS element as revealed with the SECISearch program (12) . The existence of an ascidian homologue of vertebrate deiodinases raises the hypothesis that also in protochordates the prohormone T 4 is activated by ORD to T 3 . Examination of the deduced amino acid sequence of hrDx shows that the overall homology of hrDx with other deiodinase proteins is not high (approximately 30%). Approximately the same level of homology is found if one compares any one of the vertebrate deiodinases to any of the other deiodinases. The catalytic center around the SeC residue is completely conserved, as it is in all deiodinase cDNA sequences known to date (Fig.  2) . The availability (24) of genomic and EST sequences of two other ascidian species, Ciona intestinalis and Ciona savignyi, enabled us to search for homologues of the hrDx in these sea squirts. We have identified two sequences from each species that have high homology with hrDx, namely, ciDx and ciDy for C. intestinalis and csDx and CsDy for C. savignyi. The existence of two different deiodinase-like sequences in the Ciona species is particularly interesting since it might indicate that ascidians possess not only a D1/D2-like deiodinase but also a D3-like deiodinase. Using the data for deiodinase sequences from vertebrate and invertebrate species it was possible to construct a phylogenetic tree of the deiodinases (Fig. 3) . The tree resolved into four main clusters containing the three vertebrate deiodinase subtypes, with the invertebrate deiodinases forming a seperate THYROID HORMONE DEIODINATION 789
FIG. 1.
Putative catalytic mechanism of type I deiodinase, and its inhibition by propylthiouracil (PTU), iodoacetate (IAC), and gold thioglucose (GTG).
cluster, branching close to the origin of the tree. All in all there is now sound evidence that the iodothyronine deiodinases as well as TRs arose in a urochordate, or perhaps even earlier in evolution since iodothyronines have effects on echinoderms (27, 30) such as sea urchins and sand dollars. This indicates that iodothyronines and possibly TRs and deiodinases arose earlier in evolution than receptors for gender/adrenal steroids and steroid-synthesizing enzymes. Steroid and vitamin D receptors arose in cephalochordates (for instance Amphioxus), or jawless fish such as Lamprey (31, 32) .
Biochemistry of Deiodination
Enzymatic deiodination of iodothyronines is a reductive process. This is obvious considering the substrates and products of the overall iodothyronine deiodination reaction:
Indeed, all iodothyronine deiodinases catalyze the deiodination of iodothyronines only in the presence of thiol-containing compounds such as dithiothreitol (DTT). However, it should be mentioned that for none of the deiodinases the natural cofactor has been identified with certainty, although stimulation of D1 activity has been demonstrated with the glutaredoxin system, the thioredoxin system, and dihydrolipoamide (33) (34) (35) (36) (37) . In addition, the stochiometry of the deiodination reaction has not been settled in terms of the oxidation of thiol cofactor, however, obvious this may appear from the above equation.
In view of the high degree of homology between the different deiodinases, it is logical to assume that they deiodinate their substrates by similar biochemical mechanisms. Because all iodothyronine deiodinases characterized so far have been identified as selenoproteins containing a reactive SeC residue in corresponding positions of the amino acid sequences, it is also reasonable to ascribe a special function to KUIPER ET AL. 790
FIG. 2.
Comparison of the deduced amino acid sequence of the Halocyntha roretzi (hrDx) protein with those of human (hsD1), chicken (ggD1), and tilapia (onD1) type I deiodinases; human (hsD2), chicken (ggD2), and killifish (fhD2) type II deiodinases; and human (hsD3), chicken (ggD3), and tilapia (onD3a) type III deiodinases. The SeC residue is denoted by U (residue 133 of hrDx).
the selenium in the deiodination process (9) . This is supported by observations of marked decreases in enzyme activity after replacement of Sec by Cys, or even a complete inactivation of the deiodinases if Sec is replaced by Ser, Ala, or other amino acids (see above).
Despite the high similarities between the structures of the deiodinases and the reactions they catalyze, there are also obvious differences in their catalytic properties (Table 1) . Thus, D2 catalyzes only ORD, and D3 catalyzes only IRD, whereas D1 has both ORD and IRD activities (9) . Remarkable differences in substrate specificity are also noted in particular if the behavior of sulfated iodothyronine derivatives are considered. Sulfation markedly accelerates the IRD of both T 4 and T 3 by D1, whereas ORD may either be stimulated (3,3Ј-T 2 ), unaffected (rT 3 ) or even inhibited (T 4 ) if these compounds are sulfated (38) . As far as this has been tested, D2 and D3 are incapable of deiodinating sulfated substrates.
Also the catalytic mechanisms appear to differ between the different iodothyronine deiodinases. For instance, D1 show ping-pong type enzyme kinetics, characterized by parallel lines in the Lineweaver-Burk plot of deiodination rate versus substrate concentration at different fixed cofactor concentrations (39) . This is suggestive for the alternate reaction of substrate and cofactor with different enzyme forms (the native enzyme and an enzyme intermediate generated during the catalytic cycle). In contrast, both D2 and D3 show sequential type reaction kinetics, characterized by converging lines in the Lineweaver-Burk plots at varying DTT concentration (39) . This suggests the formation of ternary enzymesubstrate-cofactor complexes during D2 and D3-catalyzed deiodinations.
Perhaps the most well-known distinction between the deiodinases is the potent inhibition of D1 by PTU in contrast to the lack of inhibition of D2 and D3 by PTU. This inhibition of D1 by PTU is uncompetitive with substrate and competitive with cofactor (DTT). These findings suggest that PTU and DTT react with the same enzyme intermediate generated from D1 during deiodination, most probably the selenenyl iodide (SeI) group (see above and Fig. 1 ). The lack of PTU inhibition of D2 and D3 would then imply that such an SeI intermediate is not generated during deiodination catalyzed by these enzymes.
However, recent findings cast doubt on the hypothesis that the catalytic mechanisms of the deiodinases are principly different. The dogma that D1 is inhibited by PTU has been contradicted by characterization of D1 from different fish species and from X. laevis that are poorly inhibited by PTU. This has been related to the amino acid two positions downstream of Sec, namely, Ser in all PTU-sensitive D1 variant, Pro in all PTU-insensitive D1, D2, and D3 enzymes (see above). Site-directed mutagenesis of Pro to Ser was shown to turn human D2 into a PTU-sensitive enzyme. In addition, it changed the kinetic mechanism of human D2 from sequential into ping-pong-type (18) . However, substitution of Ser for Pro in tilapia D1 did not increase the PTU sensitivity of this enzyme although it did change the ratio of ORD versus IRD catalysis (22) . This may be explained by additional alterations in the enzyme active center impacting on its catalytic potential, that is, the Asn to Ser mutation 6 positions upstream of the Sec residue (unplished observations). Although it remains to be determined if the lack of the hydroxyl group of Ser or the structural change associated with its replacement by Pro is the actual cause of the loss of PTU inhibition, it seems unlikely that the catalytic mechanism of the deiodinases is principly altered by the Ser-Pro interchange. Therefore, it is also unlikely that the formation of a SeI intermediate is what distinguishes the catalytic mechanism of D1 from that of D2 and D3. The generation of a SeI intermediate during the catalytic cycle of D1, and perhaps also that of D2 and D3, implies that enzymatic deiodination represents an electrophilic substitution of iodine by hydrogen. This means that iodine leaves the substrate as an iodonium (I ϩ ) ion, which would be assisted by the selenolate (Se Ϫ ) anion of Sec under formation of the SeI enzyme intermediate. However, it should be stressed that the actual formation of this SeI intermediate has not been demonstrated. This would also be a tough task, considering the instability of such a group. Also the putative covalent complex resulting form the reaction of PTU with the SeI intermediate has not been identified, which would be less of a problem, as it is thought to be a much more stable adduct.
The nucleophilic substitution of I by H in the outer ring is promoted by the electron-donating effect of the (dissociated) phenolic hydroxyl group. It is more difficult to envisage nucleophilic substitution of the outer ring iodines if this OH group is sulfated, or of the iodines in the inner ring which lacks an electron-donating OH group. It is possible that the nucleophilic substitution of iodine by hydrogen is facilitated by prior nucleophilic addition of a thiolate (S Ϫ ) or the selenolate (Se Ϫ ) group to the 2/6 or 2Ј/6Ј position (i.e., adjacent to the carbon carrying the I substituent). Such a mechanism has also been proposed for the dehalogenation of iodinated and brominated uridine derivatives by thymidylate synthetase (40) . Such a mechanism could actually be tested by analyzing the effects of substituents in the 2/6 and/or 2Ј/6Ј positions on the deiodinaton of iodothyronine derivatives.
Although the different deiodinases are integral membrane proteins located in the endoplasmic reticulum or in the plasma membrane, it is likely that they have their active centers oriented towards the cytoplasm. This is also the only compartment with a reductive environment containing high (up to 10 mM) concentrations of reduced glutathione, the most abundant intracellular thiol compound (35) . This reductive environment is essential to sustain reductive deiodination by the deiodinases. In a recent study carried out largely with cells transfected with the different types of deiodinases, evidence was obtained that D1 is localized in the plasma membrane with the largest part of the protein, including the active center, exposed to the cytoplasm. D3 was also localized in the plasma membrane but it was found to have an opposite orientation, that is, with its active site exposed on the extracellular cell surface (41) . Evidence was also obtained for rapid cycling of D3 between the plasma membrane and endosomes. These findings are in contrast to expectation since the extracellular, oxidative environment would not favor reductive deiodination by D3. Furthermore, indirect evidence in patients with mutations in the MCT8 T 3 transporter suggest that T 3 transport into the cell is required for deiodination by D3 (42, 43) . Recent studies in our laboratory involving cotransfection of cells with MCT8 and D3 support this rate-limiting role of T 3 transport across the plasma membrane for subsequent T 3 metabolism (unpublished observations). This is difficult to envisage in a situation where the D3 active center is exposed on the cell surface. Therefore, more studies are required to establish the exact subcellular location of D3.
Recently the gene coding for iodotyrosine dehalogenase (DEHAL1) has been characterized in humans and other species (44, 45) . DEHAL1 is a member of the nitroreductase family, is expressed in the thyroid, liver and kidney, and uses NADPH as the cofactor and FMN (flavin mononucleotide) as a prosthetic group for the deiodination of iodotyrosines. It seems likely that information about the biochemical mechanism of catalysis by DEHAL1 may be useful for a better understanding of the mechanism of deiodination by iodothyronine deiodinases.
Regulation of Deiodinases During Human Development
D3 in placenta and uterus
D3 plays an essential role in the regulation of the fetal thyroid hormone status. It is highly expressed in fetal tissues such as the liver (46), placenta (47) (48) (49) (50) , and pregnant uterus (51) . By immunohistochemistry, human placental D3 was shown to be located in syncytiotrophoblasts and cytotrophoblasts (49, 50) , in the fetal endothelium of chorionic villi, and in the maternal decidua (50) . Compared to the adult, plasma T 3 concentrations are very low in the fetus, whereas levels of rT 3 are more than 10-fold higher than in the adult (52) . This fetal profile has been explained by the high D3 activities in the placenta, which limits transplacental passage of maternal T 4 and T 3 to the fetus by converting T 4 to rT 3 and T 3 to 3,3Ј-T 2 during placental transfer (53, 54) .
In addition to the placenta, the uterus may also play a role in the regulation of thyroid hormone bioactivity during fetal development. It has been demonstrated that in the rat pregnant uterus over a period of 48 to 72 hours after implantation the expression of D3 is induced more than 200-fold, to levels higher than in any other tissue (51, 55) . This induction of D3 seems to be a consequence of the implantation process, since a similar increase of D3 expression is also found in artificially decidualized uterine horns, but not in undecidualized uterine horns from pseudopregnant rats (55) . Furthermore, in ovariectomized rats, Wasco et al. (55) demonstrated that estradiol and progesterone act synergistically to increase uterine D3 activity, which indicates that steroid hormones are likely to contribute to the regulation of uterine D3 expression. Immunolocalization studies have shown that initially (at embryonic day 9 [E9]) D3 is localized at the implantation site in uterine decidual tissue and later (E12 and E13) it is localized in the single cell layer of the epithelium lining the uterine lumen (51) .
In addition to the placenta and the uterus, D3 has also been demonstrated to be expressed at other maternal-fetal interfaces, such as in skin, in umbilical arteries and vein, and in the fetal respiratory, digestive and urinary tract epithelium (50) . Therefore, together with the placenta, the pregnant uterus and possibly also other sites of the maternal-fetal interface may serve to limit the exposure of the developing fetus to maternal thyroid hormone.
D1 and D3 in fetal liver
The high rT 3 versus low T 3 in fetal serum has long been considered to be the result of a combination of the high D3 activity in the placenta and a low hepatic D1 activity. Indeed, hepatic D1 activity starts to be expressed in late stages in the rat, while hepatic D3 expression is low at all stages of rat development (56, 57) . However, our study of the ontogeny of hepatic D1 and D3 during human fetal development showed that substantial D1 activity (i.e. approximately 25% of that in the normal adult) is already expressed in the human fetal liver after the first trimester, and that D3 activities are high during fetal development, declining after midgestation to lower levels around term (46) .
Therefore, in addition to the high D3 activity in the utero-placenta unit it is rather the high hepatic D3 activity than a low hepatic D1 activity that contributes to the regulation of fetal circulating T 3 levels. In agreement with this, studies in the embryonic chicken have clearly established a negative correlation between liver D3 expression and serum T 3 levels (1,58).
D2 and D3 in fetal brain and local T 3 levels
Recent literature demonstrates that thyroid hormone exerts effects on the developing central nervous system throughout a broad period of fetal and neonatal development, and that the levels of thyroid hormone required at different stages of development are critical (5) . In fact, thyroid hormone deficiency during development of the central nervous system leads to neurologic cretinism if treatment is not started immediately after birth (59) . Even undiagnosed early maternal hypothyroidism has been associated with a diminished neurologic outcome of the offspring (60, 61) . In agreement with these clinical findings, Lavado-Autric et al. (62) recently proved the sensitivity of the fetal brain to maternal thyroid hormone insufficiency: even subtle insufficiency of thyroid hormone in the pregnant rat disrupted the migration of neurons in the fetal cortex and hippocampus, leading to an altered histogenesis and cytoarchitecture of the cortex and hippocampus of the progeny.
A coordinated regulation of brain deiodinases is critical to maintain thyroid hormone homeostasis in the developing brain. D1 is not expressed in the human brain, D2 is expressed in astrocytes and tanycytes, and D3 is expressed in neurons that also express nuclear T 3 receptors and represent the major T 3 target cells in brain (63) . This suggests that astrocytes and tanycytes take up T 4 from the circulation and convert it to T 3 . Subsequently, the T 3 is transported to neurons, where the T 3 exerts its actions (63) . The D3 in the neurons would limit T 3 availability according to the local temporal needs for thyroid hormone action. In such a model a coordinated time-dependent and region-specific expression of deiodinases and of thyroid hormone transporters is of crucial importance.
We recently investigated the local regulation of thyroid hormone in the developing human brain (13-42 weeks postmenstrual age) by deiodinases, and showed that D2 and in particular D3 have key functions in this regulation (64) . We found region-specific spatial and temporal patterns of D2 and D3 activity. Also the local iodothyronine levels showed spatial and temporal specificity, which indicates that these levels could not be accounted for simply on the basis of serum iodothyronine levels. D3 activity was high in the regions with low T 3 and T 4 and high rT 3 levels, and low in regions with high T 3 and T 4 and low rT 3 levels (Fig. 4) . D3 was negatively correlated with T 3 (r ϭ Ϫ0.682) and positively with rT 3 /T 3 (r ϭ 0.812) and rT 3 /T 4 (r ϭ 0.889) (64) . In the cerebral cortex, which starts to develop in the second month of gestation, D3 activity was low to undetectable. In this brain region, T 3 and D2 activity both increased during development (64), whereas serum T 3 /T 4 tended to decrease during this same period (65) . In contrast, in the cerebellum, where major developmental events only start at week 34 (66), D3 activity was high and T 3 was low. Cerebellar D3 started to decrease after midgestation (64) .
Because D2 catalyzes the conversion of T 4 to T 3 , whereas D3 catalyzes the conversion of T 3 to 3,3Ј-T 2 and of T 4 to rT 3 , it can be concluded that coordinated D2 and D3 expression deiodination is important to keep T 3 concentrations in the developing brain tightly regulated. D2 is responsible for the local T 3 increase in the cerebral cortex, and local D3 is important to protect brain regions from undue exposure to T 3 until it is required for differentiation.
D3 and imprinting
Genomic imprinting is an epigenetic process by which the two parental alleles of a gene are differentially expressed according to the parental origin (67) . Two independent studies, one on D3 knockout mice (68) and the other on uniparental disomy (UPD) 12 mice (69), recently demonstrated that the Dio3 gene is subject to imprinting.
D3 knockout (D3-/-) mice display remarkable growth retardation and neonatal mortality (68) , which may be because of exposure to excessive levels of maternal thyroid hormone, and clearly proves the key function of D3 during development. Interestingly, the heterozygous D3ϩ/Ϫ mice showed either almost normal or strongly decreased D3 expression, depending on wether the defective allele was inherited from the mother or the father, respectively. These data led to the conclusion that the D3 gene is imprinted, with preferential expression from the paternal chromosome (68) . The Dio3 gene is located approximately 850-kb downstream of two imprinted genes, Delta-like 1 (Dlk1) and Genetrap locus 2 (Gtl2), on mouse chromosome 12F1 and on human chromosome 14q32. Tsai et al. (70) studied D3 expression and T 3 levels in UPD12 mice, that are mice that have received both homologues of chromosome 12 from only one parent. D3 mRNA expression was increased two-fold in pUPD12 embryos and placentas compared to normal embryos and placentas, whereas in mUPD12 the level was twofold decreased compared to normal (70) . Clearly, the Dio3 gene is imprinted, with preferential expression from the paternal chromosome. Disruption of the imprinting status of Dio3 in UPD12 mice resulted in abnormal serum T 3 levels: mUPD12 mice had significantly higher T 3 levels than normal, and pUPD12 mice had significantly lower T 3 levels than normal, which is in agreement with the D3 expression data (70) .
Interestingly, patients having uniparental disomy of human chromosome 14 (UPD14) have certain phenotypic characteristics, such as growth retardation (71), which are consistent with the phenotype of UPD12 mice but also of D3-deficient mice. Because the imprinting of Dio3 has important implications for the regulation of Dio3 expression, and disruption of Dio3 imprinting results in abnormal thyroid hormone levels in UPD12 mice, it is likely that the imprinting of Dio3 contributes to the phenotypic abnormalities associated with UPD12 in mice and UPD14 in humans.
Dio3 is part of a large cluster of imprinted genes, which may all be especially important during fetal development. Other genes on the locus include Dio3as, which is a noncoding gene located only 1 kb upstream of Dio3, and is transcribed antisense to the Dio3 gene (68), the paternally imprinted Dlk1 gene, which is a member of the epidermal growth factor (EGF)-like protein family and plays a role in growth of several tissues (72) , the supposedly noncoding maternally imprinted gene Gtl2, and the paternally imprinted retrotransposon-like gene Rtl1. The imprinting of Dio3 does not appear to be regulated by differential methylation at CpG islands in the GC-rich Dio3 promoter (70) . However, more distant regulatory elements may contribute to the regulation of hDio3 and other genes on the imprinted locus. Recently, an intergenic germline-specific differentially methylated region (IG-DMR) was identified on mouse chromosome 12, upstream of the Gtl2 gene (73) , which was found to be conserved between mouse and human (69) . Deletion of this IG-DMR from the maternally inherited chromosome caused the bidirectional loss of imprinting of all genes on the imprinted locus, in the case of Dio3 resulting in a doubling of D3 expression, because of the activation of the normally repressed maternal allele. Because no significant differences in the imprinting of any of the genes were found after paternal inheritance of the deletion, this IG-DMR regulates imprinting on the maternal chromosome only (69) . Despite these data, many essential regulatory elements for Dio3 expression remain unidentified. Further research should lead to the identification of such elements that regulate Dio3 imprinting or regulate its distinct expression pattern.
Genetic Variation in Deiodinase Expression
Production of thyroid hormone is regulated by the classic hypothalamic-pituitary-thyroid axis, whereas the biologic activity of thyroid hormone, that is, the availability of T 3 , is mainly regulated by the three different deiodinases (9, 74) . In healthy subjects, serum thyroid parameters show a substantial interindividual variability, whereas the intra-individual variability is within a narrow range (75, 76) . This suggests an important influence of genetic variation on the regulation of thyroid hormone bioactivity, resulting in a thyroid function set-point, that is different for each individual. These data are supported by a classical twin study that was recently published (77) . In this study, heritability accounted for approximately 65% of the variation in serum thyrotropin (TSH), free thyroxine (FT 4 ) and free triiodothyronine (FT 3 ) concentrations. In a Mexican American population, heritability in serum thyroid parameters ranged from 26%-64% of the total interindividual variation observed, whereas the effects of environmental covariates and a broad range of lifestyle covariates accounted for only 2%-18% of the total phenotypic variation (78) .
Polymorphisms are variations in the nucleotide sequence of the genome that occur at least in 1% of a population. We recently identified two polymorphisms in the D1 gene (D1a-C785T and D1b-A1814G), both located in the 3Ј-UTR, that are associated with serum thyroid parameters (79) . The T-allele of D1a was associated in a dose-dependent manner with increasing plasma rT 3 levels and decreasing T 3 /rT 3 ratio, whereas the G-allele of D1b showed an opposite tendency. D1 plays a key-role in serum T 3 production and in the clearance of rT 3 , and therefore these data suggest a negative effect of the D1a-T variant on tissue D1 activity, whereas the D1b-G variant appears to have a positive effect (79) . In a different population (350 elderly men, mean age 77 years), D1a-T showed an allele dose effect on serum T 3 concentrations, with lower T 3 levels in carriers of the D1a-T variant (80). D1b-G showed an opposite relation, which failed to reach significance. Because D1 produces serum T 3 , this is in line with our hypothesis of a decreased D1 activity in carriers of the D1a-T allele, but different from the correlations observed in healthy blood donors. This might be explained by the difference in age between the two populations (means 46 versus 77 years). A decreased T 3 production by D1 may be masked by the production of T 3 by skeletal muscle D2 in young subjects. Throughout adult life, skeletal muscle size and strength gradually decline, resulting in a decrease in D2-expressing skeletal muscle, which is believed to contribute to serum T 3 production (9). Although D1 activity decreases during aging (81, 82) , the relative contribution of D2 to serum T 3 production may be less important in elderly than in young subjects, resulting in a relatively greater contribution of D1 to serum T 3 production at advanced ages.
No effect of a polymorphism in D2, D2-Thr92Ala, was observed in blood donors (79) . However, D2 plays an important role in local T 3 production in D2-containing tissues, and therefore, an effect of this polymorphism on intracellular iodothyronine levels cannot be excluded. Mentuccia et al. (83) reported that D2-92Ala is associated with insulin resistance, but not with body composition in obese women. No significant differences in D2 activity were found between the D2-92Ala variant and the wild-type variant, after transfection in COS cells (79) . Whether this association of D2-92Ala with insulin resistance may be explained by linkage with another polymorphism, and whether it can be confirmed in other populations, remains to be investigated in future studies.
Until now, only one polymorphism has been identified in the D3 gene (D3-T1546G) (79) . This polymorphism was not associated with changes in thyroid hormone levels in healthy individuals. Possible effects of this polymorphism on tissue iodothyronine levels, and possible consequences under pathophysiological conditions (see below), remain to be investigated in future studies. A complicating aspect that may obscure genotype-phenotype correlations is the regulation of D3 expression by imprinting (see above).
In conclusion, genetic variation and, thus, polymorphisms play an important role in the interindividual variation in serum thyroid function test, suggesting a unique set-point for each individual. Subclinical hyperthyroidism and subclinical hypothyroidism illustrate that only minor alterations in thyroid hormone bioactivity may have important consequences on certain thyroid hormone-related clinical endpoints such as atherosclerosis, bone mineral density, and heart rate (84, 85) . Whether polymorphic variation in deiodinases will result in an altered risk for these clinical endpoints, can now be investigated in population studies.
Deiodinase Expression During Critical Illness
During critical illness, pronounced alterations in plasma thyroid hormone levels occur. Plasma T 3 decreases and plasma rT 3 increases, and the magnitude of these changes is related to the severity of the disease (86) . Although T 4 and FT 4 may increase in mild illness, plasma T 4 is decreased and FT 4 normal or decreased in critically ill patients (86) . Whether the reduction in serum T 3 is a beneficial adaptation resulting in a decreased metabolic rate, or that it is a maladaptation contributing to a worsening of the disease, is still a controversial issue that has been discussed extensively by others (86, 87) . So far, substitution of thyroid hormone in critically ill patients has not been shown to have a positive effect on clinical outcome, but intervention with hypothalamic-releasing factors, which restores pulsatile pituitary hormone secretion and normalizes peripheral hormone levels might be a more successful approach (88) (89) (90) . We only focus on the mechanisms behind the altered iodothyronine levels.
Until recently, studies on the role of deiodinases during critical illness have focused on D1 and D2. The reduction in circulating T 3 levels during critical illness was thought to be caused by a decreased peripheral deiodination by D1, D2, or both (9, 91, 92) . The increase in rT 3 was explained by a decreased D1 activity, because D1 is the principal pathway for rT 3 clearance (9, 74, 93) . In addition to a decreased D1 activity, an impaired transport of T 4 and rT 3 into D1 containing tissues such as liver might be an additional mechanism (94) .
However, the reciprocal changes in T 3 and rT 3 can also be explained by an induction of D3, resulting in an increased degradation of T 3 and an increased production of rT 3 . A high level of D3 expression in vascular tumors results in very low levels of circulating T 4 and T 3 , combined with high levels of rT 3 (95, 96) . This condition is referred to as consumptive hypothyroidism.
In a recent study, we analyzed perimortem serum and liver and skeletal muscle samples of 80 critically ill patients who died in a surgical intensive care unit (97) . As expected, we found low levels of TSH, T 4 , T 3 , and of the active over inactive thyroid hormone ratio (T 3 /rT 3 ), whereas we found high levels of rT 3 . In livers of these patients we found D1 activity that, except for patients who died acutely from severe brain damage, was low compared to healthy individuals. Although preliminary data suggest that D2 activity is expressed in skeletal muscle (9) , no D2 activity could be detected in skeletal muscle of these patients. On the other hand, D3, which is not present in liver and skeletal muscle in healthy individuals, was markedly induced in both liver and skeletal muscle (97) . A high D3 activity decreases the T 3 /rT 3 ratio by two ways: it prevents conversion of T 4 to T 3 by catalyzing the conversion of T 4 to rT 3 instead, and it also catalyzes the degradation of T 3 to 3,3Ј-T 2 . In these critically ill patients, liver D1 activity was positively correlated with T 3 /rT 3 ratio, whereas liver D3 tended to correlate negatively with serum T 3 /rT 3 .
It can be concluded from these data that, in addition to a downregulation of D1 and possibly D2, induction of D3 plays an important role during critical illness. D3 activity in liver and in an abundant tissue such as skeletal muscle is likely to contribute to the low serum T 3 and high serum rT 3 levels observed in critically ill patients, suggesting that the role of D3 in thyroid hormone metabolism during criticall illness was previously underestimated.
Conclusion
In both qualitative and quantitative terms, deiodination is the most important pathway of thyroid hormone metabolism. Since the molecular characterization of D1 in 1991, much progress has been made in the understanding of the molecular biology and physiology of these enzymes. One of the major achievements is the growing realization that D3 plays a much more important role in the regulation of thyroid hormone bioactivity than previously assumed. This is underscored by findings of high D3 expression in fetal tissues as well in adult tissues under pathological conditions, resulting in low T 3 levels not only locally but also systemically. Recent findings regarding the regulation of D3 expression by imprinting even add more impetus to the growing status of D3. More surprising results of the function of D3 and the other deiodinases are to be expected in the near future.
